Skip left side navigation and go to content

WORKSHOP: PARVOVIRUS B19 - IMPLICATIONS FOR TRANSFUSION MEDICINE

December 16, 1999

Natcher Auditorium, National Institutes of Health, Bethesda, MD

This workshop will provide a forum for topics related to the impact of Parvovirus B19 on transfusion practice, including the frequency of human Parvovirus B19 viremia in blood donors, the potential clinical consequences of transfusion-associated B19 infection, and issues about whether or not blood units should be screened for B19.

Agenda
Moderators: Harvey Klein and Margot Kruskall
8:20 a.m. Introduction Barbara Alving
8:30 - 10:00             Human Parvovirus B19: Epidemiology and Pathology Kevin Brown
Hematology and Immunology of B19 Infection Neal Young
10:00 -10:30 Discussion
10:30 - 12:00 Testing (NAT, IgM/IgG) Larry Anderson
Diagnosis Bernard Cohen
12:00 - 12:30 Discussion
12:30 - 1:30 Lunch
1:30 - 3:00 Blood-borne B19:
Contamination of plasma pools
Bernard Horowitz
Parvovirus infection following plasma exchange using solvent-
detergent treated pooled plasma containing parvovirus
Ted Eastlund
Blood donors Roger Dodd
Blood recipients Naomi Luban
3:00 - 3:30 Discussion
3:30 - 5:00 Directions for future research Panel discussion



Last Updated April 2011




Skip footer links and go to content
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon